Ema - activities

Covid: Sanofi's vaccine soon to be allowed in Europe

Is the Sanofi vaccine soon to be marketed? This Tuesday July 20, 2021, the European Medicines Agency has announced they are to launch a rolling review of results from phase 3 of the ongoing clinical trial of the French laboratory candidate vaccine in order to allow or not marketing issuance as soon as possible. Issuance could actually occur in the first six months of 2022, although it has been announced for late 2021.

Covid: EMA approved use of RoActemra (Tocilizumab) for severe disease

Is Tocilizumab – a Covid therapy – still under rolling review? The European Medicines Agency announced they have approved RoActemra (Tocilizumab) on hospitalized severe Covid patients. This anti-inflammatory therapy usually used against arthritis is able to bloc interleukin-6 and prevent cytokine storms, namely a secondary inflammation of the lungs.

Covid: two doses of vaccine seem to protect against the Delta variant, the EMA claims

As the Indian variant is spreading more every day, this Thursday July 1, 2021, the European Medicines Agency claims two doses of vaccine seem to protect against the Delta variant.

AstraZeneca/Janssen: thromboses explained by German searchers

German scientists are said to have discovered where thromboses caused by the AstraZeneca and Janssen vaccines come from, explaining they are caused by the vector used, the adenovirus. Keep reading to find out more.

AstraZeneca vaccine must remain limited to people aged 55+ by the Haute Autorité de Santé says

The Haute Autorité de Santé "maintains the limit of 55 years of age for Vaxzevria", aka AstraZeneca's vaccine, because of the benefit/risk ratio related to rare cases of thrombosis. This notice follows the government's demand as they wish to extend its access to all volunteering French as it is already happening in Germany.

Covid: Russian Sputnik V vaccine not to be approved before late June, Clément Beaune says

This Tuesday January 19, 2021, as the Russian authorities sought approval for issuing their Covid vaccine, Sputnik V, mostly developed by the Russian direct investment fund, from the European Medicines Agency, French State Secretary for European Affairs Clément Beaune announced the vaccine was unlikely to be approve before late June.

Covid: France's Haute Autorité de Santé approves Pfizer vaccine

COVID-19: Three days after the European Medicines Agency handed over its verdict as for issuing the vaccine developed by Pfizer and BioNTech, France's Haute Autorité de Santé allows the vaccine in France. The vaccine campaign is to begin from this Sunday Deceber 27, 2020.